People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Silexion Therapeutics Corp | — | Biotechnology | Seed | $3.6M | $9.6M | 2025 |
Mitchell Shirvan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mitchell Shirvan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ruth Alon | 1 | 2 |
| Avner Lushi | 1 | 2 |
| Ilan Hadar | 1 | 2 |
| Shlomo Noy | 1 | 1 |
| Ilan Levin | 1 | 1 |
| Dror Abramov | 1 | 1 |
| Mirit Horenshtein-Hadar | 1 | 1 |
| Amnon Peled | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.